Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with Pseudomonas.
Hasan NazikRichard B MossVyshnavi KarnaKarl V ClemonsNiaz BanaeiKevin CohenVarun ChoudharyDavid A StevensPublished in: Mycopathologia (2016)
Pseudomonas aeruginosa and Aspergillus fumigatus are the leading bacterial and fungal pathogens in cystic fibrosis (CF). We have shown that Af biofilms are susceptible to Pseudomonas, particularly CF phenotypes. Those studies were performed with a reference virulent non-CF Aspergillus. Pseudomonas resident in CF airways undergo profound genetic and phenotypic adaptations to the abnormal environment. Studies have also indicated Aspergillus from CF patients have unexpected profiles of antifungal susceptibility. This would suggest that Aspergillus isolates from CF patients may be different or altered from other clinical isolates. It is important to know whether Aspergillus may also be altered, as a result of that CF environment, in susceptibility to Pseudomonas. CF Aspergillus proved not different in that susceptibility.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- biofilm formation
- lung function
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- cell wall
- peritoneal dialysis
- prognostic factors
- acinetobacter baumannii
- atrial fibrillation
- candida albicans
- escherichia coli
- gene expression
- genome wide
- high intensity
- drug resistant
- multidrug resistant
- chronic obstructive pulmonary disease
- genetic diversity